A Study of RC118 in Patients with Locally Advanced Unresectable or Metastatic Malignant Solid Tumors

Clinical trial NCT05205850 · RECRUITING

Trial details

NCT number: NCT05205850
Sponsor: RemeGen Co., Ltd.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Solid Tumor

Start date: 2022-03-03
Primary completion: 2025-09-30
Enrollment: 135

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.